Editorial Notes
Practical guides on GLP-1 tracking, privacy-first product design, and tools that help reduce confusion instead of adding more noise.
Start here
GLP-1 medications can change your menstrual cycle. Here's what to expect, why tracking cycles alongside doses matters, and how to tell the difference between a medication side effect and a normal fluctuation.
GLP-1 medications can change your menstrual cycle. Here's what to expect, why tracking cycles alongside doses matters, and how to tell the difference between a medication side effect and a normal fluctuation.
The FDA ended compounded semaglutide and tirzepatide from 503B pharmacies. Here is what changed, what your options are, and why tracking your routine matters more than ever during a transition.
The FDA is evaluating peptides used in compounding, the MAHA Commission flagged weight-loss drugs, and peptide access is shifting. Here is what is changing and why protocol tracking matters now.
A simple weekly tracking framework for semaglutide and tirzepatide users: what to log, what to ignore, and how to stay consistent without turning progress into homework.
A practical explanation of week-to-week weight fluctuations on GLP-1 medications, why plateaus happen, and what to watch instead of reacting to every weigh-in.
A practical guide to the best GLP-1 tracking apps in 2026, including what matters most, the main app categories, and which approach best helps you understand long-term progress.